Article

Advances in cryptorchidism, VUR deliver key benefits

Dextranomer/hyaluronic acid has the potential to lower the cost and also the morbidity of repeated voiding cystourethrograms in children.

Related Videos
Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
Why a personalized approach is key to prolapse and OAB management
Anna Myers, CNP, answers a question during a Zoom video interview
Anna Myers, CNP, on the overlap between urological and gynecological conditions
Brendan Frainey, MD, on microbiome composition in patients with spina bifida
Brendan Frainey, MD, on microbiome composition in patients with spina bifida
Sarah Ponce discusses pelvic and vulvovaginal pain among medical trainees
Sarah Ponce discusses pelvic and vulvovaginal pain among medical trainees
Dr. Rosalia Misseri on using long-term data to enhance pediatric urologic care
Dr. Rosalia Misseri on using long-term data to enhance pediatric urologic care
Dr. Saraf on testicular tissue cryopreservation for pediatric patients with cancer
Dr. Saraf on testicular tissue cryopreservation for pediatric patients with cancer
Study finds overtreatment of presumed UTI in pediatric patients with spina bifida
Study finds overtreatment of presumed UTI in pediatric patients with spina bifida
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Expert offers advice on starting a sexual wellness/aesthetics practice
Patient talking with doctor | Image Credit: © bongkarn - stock.adobe.com
Expert discusses pelvic pain and vesicovaginal fistula
Shaya Taghechian, MD, answers a question during a video interview
Dr. Taghechian on her women’s sexual health practice
Related Content
FDA grants marketing authorization to at-home diagnostic test for STIs
March 28th 2025

FDA grants marketing authorization to at-home diagnostic test for STIs

Hannah Clarke
The test can deliver diagnostic results for chlamydia, gonorrhea, and trichomoniasis.
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
July 24th 2024

Speaking of Urology: Dr. Winter on the use of vaginal estrogen

Urology Times staff
In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
FDA approves gepotidacin for uncomplicated UTI
March 25th 2025

FDA approves gepotidacin for uncomplicated UTI

Hannah Clarke
The approval is supported by data from the phase 3 EAGLE-2 and EAGLE-3 trials.
Dr. Malik evaluates quality of Reddit content on recurrent UTIs
March 17th 2022

Dr. Malik evaluates quality of Reddit content on recurrent UTIs

Urology Times staff
“I think we as urologists have to be proactive in providing information to our patients so that they avoid financial harm and potentially bodily harm from this sort of misinformation,” says Rena D. Malik, MD.
FDA awards orphan drug, rare pediatric disease designations to ABO-101 for PH1
February 5th 2025

FDA awards orphan drug, rare pediatric disease designations to ABO-101 for PH1

Hannah Clarke
A phase 1/2 trial of ABO-101 is expected to launch in the first half of 2025.
Efficacy of sildenafil cream for FSAD maintained across patient subgroups
December 16th 2024

Efficacy of sildenafil cream for FSAD maintained across patient subgroups

Hannah Clarke
Age, race, and hormonal contraceptive use did not significantly impact the efficacy of sildenafil cream, 3.6%, in female sexual arousal disorder.
© 2025 MJH Life Sciences

All rights reserved.